Genesco (NYSE:GCO - Get Free Report) is expected to issue its Q1 2026 quarterly earnings data before the market opens on Friday, May 30th. Analysts expect the company to announce earnings of ($2.06) per share and revenue of $463.90 million for the quarter. Genesco has set its FY 2026 guidance at 1.300-1.700 EPS.
Genesco (NYSE:GCO - Get Free Report) last posted its quarterly earnings data on Friday, March 7th. The company reported $3.26 EPS for the quarter, missing the consensus estimate of $3.31 by ($0.05). The company had revenue of $745.95 million for the quarter, compared to analysts' expectations of $780.43 million. Genesco had a negative net margin of 1.13% and a positive return on equity of 0.56%. During the same period in the prior year, the company earned $2.59 earnings per share. On average, analysts expect Genesco to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Genesco Stock Up 3.2%
GCO opened at $21.84 on Friday. The business has a 50 day moving average price of $20.68 and a two-hundred day moving average price of $31.44. The company has a quick ratio of 0.32, a current ratio of 1.56 and a debt-to-equity ratio of 0.19. The company has a market cap of $235.39 million, a PE ratio of -8.99 and a beta of 2.14. Genesco has a 52 week low of $16.19 and a 52 week high of $44.80.
Insiders Place Their Bets
In other news, Director Gregory A. Sandfort purchased 10,974 shares of the stock in a transaction that occurred on Thursday, March 20th. The shares were acquired at an average price of $22.92 per share, for a total transaction of $251,524.08. Following the acquisition, the director now directly owns 26,754 shares in the company, valued at approximately $613,201.68. The trade was a 69.54% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Fund 1 Investments, Llc sold 12,000 shares of the company's stock in a transaction that occurred on Friday, March 28th. The stock was sold at an average price of $20.73, for a total value of $248,760.00. Following the completion of the sale, the insider now owns 1,097,850 shares in the company, valued at approximately $22,758,430.50. This represents a 1.08% decrease in their position. The disclosure for this sale can be found here. 7.09% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Genesco
A number of institutional investors and hedge funds have recently modified their holdings of GCO. Jones Financial Companies Lllp acquired a new stake in shares of Genesco in the 1st quarter worth approximately $26,000. Royal Bank of Canada lifted its stake in Genesco by 15.4% in the 1st quarter. Royal Bank of Canada now owns 52,848 shares of the company's stock valued at $1,122,000 after buying an additional 7,042 shares in the last quarter. Finally, Empowered Funds LLC lifted its stake in Genesco by 5.3% in the 1st quarter. Empowered Funds LLC now owns 64,783 shares of the company's stock valued at $1,375,000 after buying an additional 3,282 shares in the last quarter. Institutional investors and hedge funds own 94.51% of the company's stock.
Analyst Upgrades and Downgrades
GCO has been the topic of several recent analyst reports. Jefferies Financial Group dropped their target price on Genesco from $27.00 to $24.00 and set a "hold" rating on the stock in a research report on Wednesday. Wall Street Zen cut Genesco from a "buy" rating to a "hold" rating in a research report on Tuesday, April 15th.
Check Out Our Latest Report on Genesco
About Genesco
(
Get Free Report)
Genesco Inc operates as a retailer and wholesaler of footwear, apparel, and accessories in the United States, Puerto Rico, Canada, the United Kingdom, and the Republic of Ireland. The company operates through four segments: Journeys Group, Schuh Group, Johnston & Murphy Group, and Genesco Brands.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genesco, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genesco wasn't on the list.
While Genesco currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
